ISSN: 2278-0238
International Journal of Research and Development in Pharmacy & Life Sciences
黑料网
Drug Regulatory Affairs
Search results for
Drug Regulatory Affairs
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 2774
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Drug Regulatory Affairs
Drug Regulatory Affairs
Expert PPTs
- Wei Wang
Combating neglected tropical diseases
PPT Version | PDF Version - Srinivasan Shanmugam
Lipid Based Oral Drug Delivery System (LBODDS)
PPT Version | PDF Version - Vinayagam Kannan
Vinayagam_Kannan
PPT Version | PDF Version - Farnaz Monajjemzadeh
Farnaz Monajjemzadeh
PPT Version - Khosro Adibkia
Khosro Adibkia
PPT Version | PDF Version - Yazen M Alnouti
Yazen_M-Alnouti
PPT Version | PDF Version - Ioan Magyar
Introduction to Clinical Pharmacology
PPT Version | PDF Version - NAGENDRA SASTRY YARLA
Pharmacology
PPT Version | PDF Version - Zhen Yuan
Molecular imaging
PPT Version | PDF Version - You Mie Lee
Cell signalling and Biochips
PPT Version | PDF Version
Speaker PPTs
- Ivana Stojanovic
New protocol for the generation of insulin-specific T regulatory cells
| PDF Version - Sundeep Kumar Upadhyaya
LONG TERM DRUG-FREE CLINICAL-REMISSION IN PATIENTS WITH RA ON cDMARDs
| PDF Version - Jessy S Deshane
Longitudinal changes in airway microbiome signatures and immunoregulatory cell dynamics following Bronchial Thermoplasty
| PDF Version - Li Yu-Jung
Intra-maxillary Drug delivery and Bio-sensing via Dental Implant and its considerations
| PDF Version - Luis Gosalbez
Key regulatory issues in the development of pharmabiotics in Europe
| PDF Version - Carsten Worsoe
The value of the 脙垄芒聜卢脜聯simulated study脙垄芒聜卢脗聺 as a tool to predict actual leachables in parenteral drug products
| PDF Version - Diane Paskiet
Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
| PDF Version - Li-Chun Tsou
Drug delivery device strategy for patient centric therapies
| PDF Version - Neervalur V Raghavan
Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
| PDF Version - Panayiotis P Constantinides
Parenteral Drug Nanodispersions : Manufacturing, Characterization and In Vitro/In Vivo Performance Evaluation
| PDF Version - Jan Voskuil
How antibodies can prevent medical progress and how they can be great tools?
| PDF Version - Arshad mahmood
TRANSPORT OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) ACROSS MUCUS AND CELLULAR INTERNALIZATION
| PDF Version - Kazuo Yano
Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
| PDF Version - Hugo Albrecht
Towards pharmacological validation of MNKs as anti-cancer drug targets
| PDF Version - Vivek Lal
New drug development in type-2 diabetes mellitus : current and future trends 脙垄芒聜卢芒聙聹 an overview
| PDF Version - Joan Smith Sonneborn
Novel anti-retroviral drug targets: Interfering siRNA and mitochondrial TERT expression
| PDF Version - Barbara Klajnert-Maculewicz
Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
| PDF Version - Adel Nefzi
脙垄芒聜卢脜聯Adel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discovery脙垄芒聜卢脗聺
| PDF Version - Tanvir Ahmed
Sexual partners and condom use attitude: Qualitative findings among injecting drug users in Hai Phong, Vietnam
| PDF Version - Mukesh Kumar
Membrane fusion mediated cytosolic drug delivery through scFv targeted Sendai viral envelopes
| PDF Version - Jan O Gordeladze
Key regulatory junctions stabilizing the osteoblast phenotype: Implications for cell and tissue engineering
| PDF Version - Thomas J Franz
Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
| PDF Version - Rinat Islamov
Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
| PDF Version - Almas Okassov
Chemical modification of anticancer Parasporins for decreasing of their toxicity
| PDF Version - Akujobi Comfort
Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
| PDF Version - Sevgi Gungor
Micelles as nanosized carriers for skin delivery of drugs
| PDF Version - Ru Band Lu
Anti-Inflammation and neuroprotective drugs benefit the treatment of heroin dependent patients
| PDF Version - Helmi Mardassi
A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
| PDF Version - Sungchul Ji
Mathematical Models of RNA Expression Profiles: Potential Applications to Drug Discovery Research and Personalized Medicine
| PDF Version - Anita Nair
BCS-Based Biowaivers: Which Drugs are Eligible?
| PDF Version - Adriana Katz
Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
| PDF Version - Eggehard Holler
Biodegradable nanobrushes for drug delivery
| PDF Version - Tao Lu
Using VBIM technique to identify drug resistance genes in ovarian cancer
| PDF Version - Magali Cordaillat-Simmons
Pharmabiotics: A regulatory hurdle in Europe
| PDF Version - Navneet Sharma
Transdermal patches based on solid lipid nanoparticles of Metformin: Novel approach for drug delivery of Type 2 diabetes
| PDF Version - Viral Kansara
Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
| PDF Version - Richard A. Kenley
Equilibrium binding interactions between lotrafilcon a soft contact lenses and the two prostaglandin anti-glaucoma drugs Bimatoprost and Tafluprost
| PDF Version - Elena Gavrilova
Application of drugs based on release-active antibodies as immunotherapy agents
| PDF Version - William Lee
Regulatory roadmap for initiating a cell therapy drug into clinical trials in the US
| PDF Version - Ricardo Ibarra-Cabrera
Business and regulatory environment of biopharmaceuticals and biosimilars in Latin America
| PDF Version - Krasimira Pekova
Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines
| PDF Version - Jasmin Kaur
Helping clinicians connect: Understanding addiction from the perspective of a drug abuser
| PDF Version - Matin Peters
Cognitive-behavioral therapy as an effective treatment method in the ASEAN setting
| PDF Version - Marcelo Febo
3,4-Methylenedioxypyrovalerone (MDPV), a major bath salt drug, reduces functional connectivity in rat brain
| PDF Version - Rafael Correa-Rocha
HIV infection of Human regulatory T cells (Treg) downregulates Foxp3 expression and produces a loss of the suppressive capacity of these cells
| PDF Version - Jim Klostergaard
Magnetic vectoring for drug delivery to tumors: Past, present and is there a future?
| PDF Version - Sree Harsha
Optimization of particles size for lung specific drug delivery by way of microspheres
| PDF Version - Mauro Comes Franchini
Gold, silver magnesium and magnetic nanoparticles: Nanomedicine applications in drug delivery
| PDF Version - W Wagner
Tumor regression by means of magnetic drug targeting
| PDF Version - Amin A. Fadl
Biological and Pathogenic Regulatory Role of Salmonella gidAB Operon
| PDF Version - Jung-Joon Min
Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
| PDF Version - Maria Paola COSTI
A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
| PDF Version - Vladimir Torchilin
Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
| PDF Version - Gerlies Treiber
Vitamin D: Should a regular dose be part in immunomodulation of regulatory T cells in immunomediated diseases?
| PDF Version - Baharudin Ibrahim
Personalizing drug treatment using pharmacometabonomic approach
| PDF Version - Ruben Artero
A Drosophila high-throughput drug screening platform identifies inhibitors of misregulated alternative splicing events in myotonic dystrophy
| PDF Version - Vladimir E. Bondarenko
Mathematical model of 脙聨脗虏1-adrenergic signaling in mouse ventricular myocytes as an in silico tool for the cardiovascular drug test
| PDF Version - Maria ISAGULIANTS
DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
| PDF Version - Grace London
Development of aptamer based HIV-1 entry inhibitor prophylactic drugs
| PDF Version - Aina Westrheim Ravna
Novel sildenafil analogues: possible drugs for increased sensitivity to chemotherapeutic agents
| PDF Version